These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25304451)

  • 1. [Vaccination against meningococcal B disease. Public statement of the Advisory Committee on Vaccines of the Spanish Association of Paediatrics (CAV-AEP)].
    Moreno-Pérez D; Álvarez García FJ; Arístegui Fernández J; Cilleruelo Ortega MJ; Corretger Rauet JM; García Sánchez N; Hernández Merino A; Hernández-Sampelayo Matos T; Merino Moína M; Ortigosa Del Castillo L; Ruiz-Contreras J;
    An Pediatr (Barc); 2015 Mar; 82(3):198.e1-9. PubMed ID: 25304451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neisseria meningitidis B vaccines.
    Panatto D; Amicizia D; Lai PL; Gasparini R
    Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunisation schedule of the Spanish Association of Paediatrics: 2013 recommendations].
    Moreno-Pérez D; Álvarez García FJ; Arístegui Fernández J; Barrio Corrales F; Cilleruelo Ortega MJ; Corretger Rauet JM; González-Hachero J; Hernández-Sampelayo Matos T; Merino Moína M; Ortigosa Del Castillo L; Ruiz-Contreras J;
    An Pediatr (Barc); 2013 Jan; 78(1):59.e1-27. PubMed ID: 23228438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quadrivalent meningococcal conjugate vaccines.
    Pace D; Pollard AJ; Messonier NE
    Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease.
    Watson PS; Turner DP
    Vaccine; 2016 Feb; 34(7):875-80. PubMed ID: 26686570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations].
    Moreno-Pérez D; Alvarez García FJ; Arístegui Fernández J; Cilleruelo Ortega MJ; Corretger Rauet JM; García Sánchez N; Hernández Merino A; Hernández-Sampelayo Matos T; Merino Moína M; Ortigosa Del Castillo L; Ruiz-Contreras J;
    An Pediatr (Barc); 2014 Jan; 80(1):55.e1-55.e37. PubMed ID: 24412025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pros and cons of vaccination against serogroup B meningococcal disease.
    Delgado Rodríguez M; Domínguez García Á
    Med Clin (Barc); 2018 Feb; 150(3):109-113. PubMed ID: 28992986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paediatric meningococcal meningitis in France: ACTIV/GPIP network results].
    Levy C; Taha MK; Bingen E; Cohen R;
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S49-54. PubMed ID: 22883366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of serogroup B meningococcal disease using a four-component vaccine].
    Gil A; Barranco D; Batalla J; Bayas JM; Campins M; Gorrotxategi Gorrotxategi P; Lluch J; Martinón-Torres F; Mellado MJ; Moreno-Pérez D; Uriel B; Vázquez JA
    An Pediatr (Barc); 2014 Apr; 80(4):259.e1-23. PubMed ID: 24119683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The decline of the incidence of meningococcal disease in Barcelona between 1988 and 2015: the influence of the vaccine against serogroup C.
    Manzanares-Laya S; Parés-Badell O; Gorrindo P; Simón P; Ros M; de Andrés A; López Segura N; Brió Sanagustín S; Vilella A; Rodrigo Gonzalo de Liria C; Orcau À; Caylà JA
    Med Clin (Barc); 2018 Nov; 151(10):390-396. PubMed ID: 29503027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serogroup B meningococcal vaccines.
    Zimmer SM; Stephens DS
    Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards an improved serogroup B Neisseria meningitidis vaccine.
    Perrett KP; Pollard AJ
    Expert Opin Biol Ther; 2005 Dec; 5(12):1611-25. PubMed ID: 16318425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease.
    Zlotnick GW; Jones TR; Liberator P; Hao L; Harris S; McNeil LK; Zhu D; Perez J; Eiden J; Jansen KU; Anderson AS
    Hum Vaccin Immunother; 2015; 11(1):5-13. PubMed ID: 25483509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunisation schedule of the Spanish Association of Paediatrics: 2017 recommendations].
    Moreno-Pérez D; Álvarez García FJ; Arístegui Fernández J; Cilleruelo Ortega MJ; Corretger Rauet JM; García Sánchez N; Hernández Merino Á; Hernández-Sampelayo Matos T; Merino Moína M; Ortigosa Del Castillo L; Ruiz-Contreras J;
    An Pediatr (Barc); 2017 Feb; 86(2):98.e1-98.e9. PubMed ID: 28038948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacterial meningitis caused by Neisseria meningitidis. Prophylactic measures].
    Magdzik W
    Przegl Epidemiol; 2004; 58(2):241-51. PubMed ID: 15521103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunisation schedule of the Spanish Association of Paediatrics: 2016 recommendations].
    Moreno-Pérez D; Álvarez García FJ; Arístegui Fernández J; Cilleruelo Ortega MJ; Corretger Rauet JM; García Sánchez N; Hernández Merino A; Hernández-Sampelayo Matos T; Merino Moína M; Ortigosa del Castillo L; Ruiz-Contreras J;
    An Pediatr (Barc); 2016 Jan; 84(1):60.e1-13. PubMed ID: 26589473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal vaccine evolution.
    Bona G; Guidi C
    J Prev Med Hyg; 2012 Sep; 53(3):131-5. PubMed ID: 23362617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunisation schedule of the Spanish Association of Paediatrics: 2015 recommendations].
    Moreno-Pérez D; Álvarez García FJ; Arístegui Fernández J; Cilleruelo Ortega MJ; Corretger Rauet JM; García Sánchez N; Hernández Merino A; Hernández-Sampelayo Matos T; Merino Moína M; Ortigosa Del Castillo L; Ruiz-Contreras J;
    An Pediatr (Barc); 2015 Jan; 82(1):44.e1-44.e12. PubMed ID: 25554656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination].
    Goicoechea Sáez M; Fullana Montoro AM; Momparler Carrasco P; Redondo Gallego MJ; Brines Solanes J; Bueno Cañigral FJ
    Rev Esp Salud Publica; 2003; 77(1):125-42. PubMed ID: 12696392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention.
    Esposito S; Castellazzi L; Bosco A; Musio A; Stoddard J
    Immunotherapy; 2014; 6(4):395-408. PubMed ID: 24815780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.